bluebird bio, Inc. Gains 50.45%
Wed, May 14, 2025 at 07:02 PM
bluebird bio, Inc. (BLUE:NASDAQ) shot up at $4.98, a gain of 50.5%. On Wed, May 14, 2025, BLUE:NASDAQ touched a New 2-Week High of $4.98. The stock appeared on our News Catalysts scanner on Wed, May 14, 2025 at 10:38 AM in the 'AGREEMENT' category. From Wed, Apr 30, 2025, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Dec 04, 2024 at $15.4 with a volume of 3M+.
About bluebird bio, Inc. (BLUE:NASDAQ)
bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.
Top 10 Gainers:
- Incannex Healthcare Inc. (IXHL:NASDAQ), 720.63%
- Klotho Neurosciences, Inc. (KLTO:NASDAQ), 122.46%
- Primega Group Holdings Limited (PGHL:NASDAQ), 95.64%
- Hempacco Co., Inc. (HPCO:NASDAQ), 87.5%
- NWTN Inc. (NWTN:NASDAQ), 76.47%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 59.54%
- Garden Stage Limited (GSIW:NASDAQ), 54.55%
- Newegg Commerce, Inc. (NEGG:NASDAQ), 53.65%
- Septerna, Inc. (SEPN:NASDAQ), 50.97%
- bluebird bio, Inc. (BLUE:NASDAQ), 50.45%